Results 141 to 150 of about 61,475 (266)

Micronests in Tumor Stroma is a Prognostic Classifier in Nasopharyngeal Carcinoma. [PDF]

open access: yesAm J Surg Pathol
Almangush A   +5 more
europepmc   +1 more source

HNRNPD Induces Radioresistance in Nasopharyngeal Carcinoma by Sequestering GRAMD4 mRNA in Stress Granules

open access: yesAdvanced Science, Volume 13, Issue 43, 3 August 2026.
HNRNPD promotes radioresistance in nasopharyngeal carcinoma by enhancing stress granule assembly and sequestering GRAMD4 mRNA. This suppresses GRAMD4 translation and inhibits mitochondrial apoptosis. Targeting the integrated stress response with ISRIB restores GRAMD4 expression and sensitizes tumors to radiotherapy, revealing a translational control ...
Yingzi Li   +13 more
wiley   +1 more source

Altered Nasal Microbiota in Sinonasal Tumors: A Comparative Analysis of Malignant and Benign Sinonasal Tumors

open access: yesInternational Forum of Allergy &Rhinology, Volume 16, Issue 8, Page 778-787, August 2026.
ABSTRACT Background Although shifts in nasal microbiota have been well‐documented in inflammatory upper airway conditions, microbiota tumor‐associated alterations remain uncharacterized. This study is the first to compare sinonasal microbiota profiles of patients with malignant tumors (MT), benign tumors (BT), and controls, offering insights into tumor‐
Evan A. Patel   +13 more
wiley   +1 more source

Therapeutic Applications of Stimuli‐Based Release and Engineering of Extracellular Vesicles

open access: yesAdvanced NanoBiomed Research, Volume 6, Issue 8, August 2026.
This review summarizes the effects of endogenous and exogenous stimuli, their effects on the natural release of extracellular vesicles, as well as their uptake and release. It also gives an overview of stimuli‐responsive EVs and their therapeutic applications. Extracellular vesicles (EVs), nano‐ to microsized lipid bilayer membrane‐bound particles, are
Gloria Kemunto, Kristen Dellinger
wiley   +1 more source

Advances in the Research of Nasopharyngeal Carcinoma: A Perspective

open access: yesCancer Innovation, Volume 5, Issue 4, August 2026.
The year 2025 marks a paradigm shift in nasopharyngeal carcinoma management towards greater precision, reduced toxicity, and enhanced intelligence. This review highlights the key breakthroughs from 2025 in clinical trials, technological innovations, and basic research for NPC, offering insights for clinical practice and future investigations.
Zishan Liang   +5 more
wiley   +1 more source

Patterns of regional recurrences after treatment of nasopharyngeal carcinoma. [PDF]

open access: yesRadiat Oncol
Lin Y   +6 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy